Efficacy and clinical relevance of vilazodone in the treatment of major depressive disorder : A pooled analysis of phase III clinical trials

被引：0
|
作者：
Khan, A. [1 ]
Song, W. [2 ]
Ruth, A. [3 ]
Edwards, J. [4 ]
机构：
[1] Duke Univ, Bellevue, WA USA
[2] Forest Res Inst, Jersey City, NJ USA
[3] Prescott Med Commun Grp, Chicago, IL USA
[4] Forest Res Inst, Jersey City, NJ USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2012年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-14-022
引用
收藏
页码：186 / 187
页数：2
相关论文
共 50 条
  • [1] EFFICACY AND CLINICAL RELEVANCE OF VILAZODONE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER: A POOLED ANALYSIS OF PHASE III CLINICAL TRIALS
    Culpepper, Larry
    Khan, Arif
    Ruth, Adam
    Edwards, John
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2013, 28 : S71 - S72
  • [2] Efficacy and clinical relevance of vilazodone in the treatment of major depressive disorder: a pooled analysis of phase III clinical trials
    Khan, A.
    Song, W.
    Edwards, J.
    Ruth, A.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S253 - S254
  • [3] Efficacy of escitalopram monotherapy in the treatment of major depressive disorder A pooled analysis of 4 Chinese clinical trials
    Li, Guanjun
    Shen, Yifeng
    Luo, Jianfeng
    Li, Huafang
    [J]. MEDICINE, 2017, 96 (39)
  • [4] Efficacy and Safety of Vilazodone treatment for Major Depressive Disorder (MDD): A Pooled analysis of 3390 patients
    Gbreel, Mohamed Ibrahim
    Al-Kafarna, Mohammed
    Almaghary, Bashar Khaled
    Sabra, Hamdy Khaled
    Adwan, Mustafa
    Abdelgawad, Osama Khalid
    Elsheikh, Fatma
    Abdullah, Ahmed Mahmoud
    Almadhoon, Hossam Waleed
    Amer, Esraa Abdelhameid
    Elsnhory, Ahmed
    [J]. NEUROLOGY, 2023, 100 (17)
  • [5] Citalopram and escitalopram in the treatment of major depressive disorder: A pooled analysis of 3 clinical trials
    Li, Huafang
    Li, Ting
    Li, Guanjun
    Luo, Jianfeng
    [J]. ANNALS OF CLINICAL PSYCHIATRY, 2014, 26 (04) : 281 - 287
  • [6] The Preclinical and Clinical Effects of Vilazodone for the Treatment of Major Depressive Disorder
    Sahli, Zeyad T.
    Banerjee, Pradeep
    Tarazi, Frank I.
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2016, 11 (05) : 515 - 523
  • [7] Early improvement and sustained response with vilazodone in patients with major depressive disorder - pooled analyses from phase III trials
    Jain, R.
    Chen, D.
    Edwards, J.
    Mathews, M.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S326 - S326
  • [8] Duloxetine for the treatment of major depressive disorder. A review of phase III clinical trials
    Arrazola Saniger, M.
    Castells Molina, S.
    Ogayar Luque, M.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 99 : 27 - 27
  • [9] Vilazodone improves anxiety symptoms in patients with major depressive disorder: a pooled analysis of efficacy
    Edwards, J.
    Chen, D.
    Ruth, A.
    Thase, M. E.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S325 - S326
  • [10] Efficacy and tolerability of vilazodone for major depressive disorder: evidence from phase III/IV randomized controlled trials
    Shi, Ligen
    Wang, Jingyi
    Xu, Shenbin
    Lu, Yunrong
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 3899 - 3907
12345